在高血压的老年人中估计RASA药物坚持的最佳门
Megha A Parikh1, Sujith Ramachandran2, Irene Nsiah2
1Pharmacy Quality Alliance, Alexandria, VA.
Journal of managed care & specialty pharmacy
|January 2, 2025
概括
在医疗保险优势计划中,更高的宁-血管酶系统抗剂 (RASA) 药物坚持率与更少的住院病例和更低的成本有关. 该研究表明,最佳比例的覆盖日 (PDC) 门高于目前的80%标准.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 药物经济学 药物经济学
- 改善医疗保健的质量
背景情况:
- 医疗保险和医疗补助服务中心 (CMS) 的星级评级计划使用药物坚持作为质量指标.
- 目前对氨酸 - ангиотензин系统抗剂 (RASAs) 的坚持措施使用80%的覆盖天数 (PDC) 门.
研究的目的:
- 评估RASA药物坚持和医疗保健资源利用在Medicare Advantage中的关联.
- 为了确定最大化经济和利用效益的最佳PDC门.
主要方法:
- 使用行政索赔数据 (2015-2018) 的回顾性队列研究.
- 基于医疗保险D部分星级评级RASA措施规范的纳入标准.
- 分析一年的坚持以及随后的医疗保健利用率和成本.
主要成果:
- 总共有1,006,901个人被分析,平均PDC为87.5%.
- 增加的PDC与住院和急诊室 (ED) 访问的几率降低以及医疗费用降低有关.
- 为了最大限度地减少不良结果,PDC的最佳值在90.4%至91.5%之间.
结论:
- 在医疗保险优势中,更高的药物坚持,特别是RASAs,对于预防住院,急救诊所和高医疗费用至关重要.
- 对于RASA坚持的最佳PDC值似乎高于当前80%的CMS标准.
- 建议进行进一步的研究,以评估调整的坚持值对临床和经济结果的影响.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
299
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
01:25Antihypertensive Drugs: Direct Renin Inhibitors
437
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
437
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
373
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
373
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
509
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
509
01:18Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
01:28Special considerations while measuring blood pressure
688
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
688